- Acted for Bright Minds Biosciences Inc. in connection with its prospectus and listing on the Canadian Securities Exchange, 2021
- Acted for Bright Minds Biosciencess Inc. in an overnight marketed short form prospectus for gross proceeds of $25.9 million, March 2021
- Acted for Turmalina Metals Corp. in an overnight marketed prospectus offering for gross proceeds of $8,500,000, February 2020
- Acted for Turmalina Metals Corp. in connection with its prospectus and listing on the TSX Venture Exchange, 2019
- Acted for Aurora Cannabis Inc. in connection with its acquisition of Whistler Medical Marijuana Corporation valued at $175,000,000.
- Acted for Harvest One Cannabis Inc. (formerly Harvest One Capital Inc.) in its qualifying transaction involving the acquisition of 100% of the issued and outstanding shares of each of United Greeneries Holdings Ltd. from MMJ PhytoTech Limited and Satipharm AG from PhytoTechMedical (UK) Pty Ltd., a wholly subsidiary of MMJ PhytoTech Limited, and a related brokered $25,000,000 subscription receipt offering
- Acts for various TSX Venture Exchange and Canadian Securities Exchange listed issuers in brokered and non-brokered debt and equity financings
- Acts for companies completing going public transactions including reverse takeovers on the TSX Venture Exchange and Canadian Securities Exchange
- Acts for Capital Pool Companies and businesses in completing “qualifying transactions” pursuant to the TSX Venture Exchange CPC program
- Acted for VMS Ventures Inc. while Royal Nickel Corporation was purchasing it for a total consideration of $21.1 million, April 2016
Sasa Jarvis is a respected capital markets and securities lawyer. Her practice focuses primarily on corporate and securities law matters, where Sasa advises both private and public clients on a range of transactions. Her experience includes financings of public and private companies, initial public offerings, listings, mergers and acquisitions, and continuous disclosure obligations.
Representing clients in various industries, Sasa works extensively with clients in the mining and life sciences sectors. As part of her mining practice, Sasa advises public and private companies with respect to property option agreements, acquisitions of mineral properties, asset purchase and sale transactions, joint ventures, as well as technical disclosure.
Sasa’s life sciences practice includes providing advice to companies operating in highly regulated spaces, including cannabis and psychedelics, including on transactional and corporate compliance matters, going public transactions, raising funds, and continuing to comply with disclosure and other requirements. She has assisted clients in the cannabis space since the firm established its dedicated practice in 2016, and is a frequent writer and speaker on developments in Canadian law as they relate to psychedelic regulation.
Expertise
Representative Matters
Speaking Engagements
“Legislative Update”, Advanced Securities 2020 Series, Continuing Legal Education Society of British Columbia
June 2020News
Media Mentions
- “The new cannabis? – The drive towards allowing psychedelics such as magic mushrooms for some uses is gaining momentum“, by Luis Millàn, CBA/ABC National (September 27, 2021)
Directorships & Affiliations
- Past Co-Chair of SOGIC-BC, a section of the Canadian Bar Association in British Columbia
- Law Society of British Columbia
Education & Admissions
Publications
- “The Energy Statutes Amendment Act – British Columbia’s New Regulatory Regime and New Liabilities for the Energy Industry,” Co-authored with Ralph Cuervo-Lorens, Sean Ralph and Jordan Ghag, Energy Regulation Quarterly – Volume 11, Issue 3 (October 2023)
- “Foreign investment in critical minerals,” The Canadian Mining Journal (May 2023)
- “Canada’s growing psychedelics industry has reason to pay attention to B.C. decriminalization decision,” The Globe and Mail (July 2, 2022)
Insights (25 Posts)View More
Deals & Cases (4 Posts)
Get updates delivered right to your inbox. You can unsubscribe at any time.